EP Patent

EP0009384A1 — Processes for the preparation of triazinones and condensed triazinones, and compounds so obtained

Assigned to Glaxo Group Ltd · Expires 1980-04-02 · 46y expired

What this patent protects

Compounds of the formula (I)(in which X represents HS- or a group R,R<sub>2</sub>N- wherein R, and R<sub>2</sub> which may be the same or different represent hydrogen or a straight or branched chain alkyl group containing from 1 to 4 carbon atoms or a benz…

USPTO Abstract

Compounds of the formula (I)(in which X represents HS- or a group R,R<sub>2</sub>N- wherein R, and R<sub>2</sub> which may be the same or different represent hydrogen or a straight or branched chain alkyl group containing from 1 to 4 carbon atoms or a benzyl group and R<sub>3</sub> represents a C<sub>3-2</sub> alkyl group or a C<sub>3-2</sub> cycloalkyl group) are prepared by reacting an α-ketoester of the formula (II)(in which Alk represents an alkyl group) or a precursor thereof with a compound of the formula (III)The precursor of the compound of formula (II) may be a mixture of isomeric enol estersThe compounds of formula (I) may be converted into compounds of formula (VIII)in which R, and R<sub>2</sub> which may be the same or different represent hydrogen or a straight or branched chain alkyl group containing from 1 to 4 carbon atoms, and R<sub>3</sub> is as defined above.

Drugs covered by this patent

Patent Metadata

Patent number
EP0009384A1
Jurisdiction
EP
Classification
Expires
1980-04-02
Drug substance claim
No
Drug product claim
No
Assignee
Glaxo Group Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.